On January 16, the Food and Drug Administration (FDA) published a notice announcing that the voluntary direct-to-consumer (DTC) television advertisement user fee program authorized by the Food and Drug Administration Amendments Act of 2007 (FDAAA) will not be implemented at this time, since $11.25 million in user fees were not appropriated by Congress or promised by firms in advance of the program. Under the FDAAA, firms were required to estimate in advance how many DTC TV advertisements they would submit to FDA during 2008 for pre-review and, based on that number, user fees would be assessed. Not enough advertisements were projected for review during 2008 to raise the required $11.25 million to begin the program, which would have provided for increased staff and resources to conduct such pre-reviews. As permitted under the FDAAA, the FDA will not implement the DTC TV ad user fee program and, therefore, has withdrawn its December 11, 2007 notice establishing user fee rates for the program for FY 2008. Advertisements voluntarily submitted to the FDA will be reviewed with existing resources in as timely a manner as such resources permit.